Glycogen synthase kinase 3-β phosphorylates novel S/T-P-S/T domains in Notch1 intracellular domain and induces its nuclear localization
被引:25
|
作者:
Han, Xiangzi
论文数: 0引用数: 0
h-index: 0
机构:
Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South Korea
Yanbian Univ, Coll Med, Dept Prevent Med, Yanji, Peoples R ChinaHanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South Korea
Han, Xiangzi
[1
,2
]
Ju, Ji-Hyun
论文数: 0引用数: 0
h-index: 0
机构:
Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South KoreaHanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South Korea
Ju, Ji-Hyun
[1
]
Shin, Incheol
论文数: 0引用数: 0
h-index: 0
机构:
Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South KoreaHanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South Korea
Shin, Incheol
[1
]
机构:
[1] Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South Korea
[2] Yanbian Univ, Coll Med, Dept Prevent Med, Yanji, Peoples R China
We identified two S/T-P-S/T domains (2122-2124, 2126-2128) inducing Notch intracellular domain (NICD) nuclear localization. The GFP-NICD (1963-2145) fusion protein deletion mutant without classical NLS was localized in the nucleus like the full length GFP-NICD. However, quadruple substitution mutant (T2122A T2124A S2126A T2128A) showed increased cytoplasmic localization. GSK-3 beta enhanced nuclear localization and transcriptional activity of WT NICD but not of quadruple substitution mutant. In vitro kinase assays revealed that GSK-3 beta phosphorylated S and T residues in NICD S/T-p-S/T domains. These results suggest that the novel SIT-P-SIT domain, phosphorylated by GSK-3 beta is also involved in the nuclear localization of NICD as well as classical NLS. (C) 2012 Elsevier Inc. All rights reserved.
机构:
Takeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, JapanTakeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan
Onishi, Tomohiro
Iwashita, Hiroki
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, JapanTakeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan
Iwashita, Hiroki
Uno, Yumiko
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, JapanTakeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan
Uno, Yumiko
Kunitomo, Jun
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, Med Chem Res Labs, Div Pharmaceut Res, Osaka 5328686, JapanTakeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan
Kunitomo, Jun
Saitoh, Morihisa
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, Med Chem Res Labs, Div Pharmaceut Res, Osaka 5328686, JapanTakeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan
Saitoh, Morihisa
Kimura, Eiji
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, Med Chem Res Labs, Div Pharmaceut Res, Osaka 5328686, JapanTakeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan
Kimura, Eiji
Fujita, Hisashi
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, Discovery Res Ctr, Div Pharmaceut Res, Osaka 5328686, JapanTakeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan
Fujita, Hisashi
Uchiyama, Noriko
论文数: 0引用数: 0
h-index: 0
机构:Takeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan
Uchiyama, Noriko
Kori, Masakuni
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, Med Chem Res Labs, Div Pharmaceut Res, Osaka 5328686, JapanTakeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan
Kori, Masakuni
Takizawa, Masayuki
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, JapanTakeda Pharmaceut Co Ltd, Pharmacol Res Labs, Div Pharmaceut Res, Osaka 5328686, Japan